EANM guidelines for ventilation/perfusion scintigraphy : Part 2. Algorithms and clinical considerations for diagnosis of pulmonary emboli with V/P(SPECT) and MDCT.
(2009) In European Journal of Nuclear Medicine and Molecular Imaging- Abstract
- As emphasized in Part 1 of these guidelines, the diagnosis of pulmonary embolism (PE) is confirmed or refuted using ventilation/perfusion scintigraphy (V/P(SCAN)) or multidetector computed tomography of the pulmonary arteries (MDCT). To reduce the costs, the risks associated with false-negative and false-positive diagnoses, and unnecessary radiation exposure, preimaging assessment of clinical probability is recommended. Diagnostic accuracy is approximately equal for MDCT and planar V/P(SCAN) and better for tomography (V/P(SPECT)). V/P(SPECT) is feasible in about 99% of patients, while MDCT is often contraindicated. As MDCT is more readily available, access to both techniques is vital for the diagnosis of PE. V/P(SPECT) gives an effective... (More)
- As emphasized in Part 1 of these guidelines, the diagnosis of pulmonary embolism (PE) is confirmed or refuted using ventilation/perfusion scintigraphy (V/P(SCAN)) or multidetector computed tomography of the pulmonary arteries (MDCT). To reduce the costs, the risks associated with false-negative and false-positive diagnoses, and unnecessary radiation exposure, preimaging assessment of clinical probability is recommended. Diagnostic accuracy is approximately equal for MDCT and planar V/P(SCAN) and better for tomography (V/P(SPECT)). V/P(SPECT) is feasible in about 99% of patients, while MDCT is often contraindicated. As MDCT is more readily available, access to both techniques is vital for the diagnosis of PE. V/P(SPECT) gives an effective radiation dose of 1.2-2 mSv. For V/P(SPECT), the effective dose is about 35-40% and the absorbed dose to the female breast 4% of the dose from MDCT performed with a dose-saving protocol. V/P(SPECT) is recommended as a first-line procedure in patients with suspected PE. It is particularly favoured in young patients, especially females, during pregnancy, and for follow-up and research. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1452838
- author
- Bajc, Marika LU ; Neilly, J ; Miniati, M ; Schuemichen, C ; Meignan, M and Jonson, Björn LU
- organization
- publishing date
- 2009-07-24
- type
- Contribution to journal
- publication status
- published
- subject
- in
- European Journal of Nuclear Medicine and Molecular Imaging
- publisher
- Springer
- external identifiers
-
- pmid:19629478
- scopus:68949212847
- pmid:19629478
- ISSN
- 1619-7070
- DOI
- 10.1007/s00259-009-1169-y
- language
- English
- LU publication?
- yes
- id
- 103b055b-fafb-42bb-a6ee-343a5f91b88d (old id 1452838)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/19629478?dopt=Abstract
- date added to LUP
- 2016-04-04 07:33:03
- date last changed
- 2022-02-20 20:35:22
@article{103b055b-fafb-42bb-a6ee-343a5f91b88d,
abstract = {{As emphasized in Part 1 of these guidelines, the diagnosis of pulmonary embolism (PE) is confirmed or refuted using ventilation/perfusion scintigraphy (V/P(SCAN)) or multidetector computed tomography of the pulmonary arteries (MDCT). To reduce the costs, the risks associated with false-negative and false-positive diagnoses, and unnecessary radiation exposure, preimaging assessment of clinical probability is recommended. Diagnostic accuracy is approximately equal for MDCT and planar V/P(SCAN) and better for tomography (V/P(SPECT)). V/P(SPECT) is feasible in about 99% of patients, while MDCT is often contraindicated. As MDCT is more readily available, access to both techniques is vital for the diagnosis of PE. V/P(SPECT) gives an effective radiation dose of 1.2-2 mSv. For V/P(SPECT), the effective dose is about 35-40% and the absorbed dose to the female breast 4% of the dose from MDCT performed with a dose-saving protocol. V/P(SPECT) is recommended as a first-line procedure in patients with suspected PE. It is particularly favoured in young patients, especially females, during pregnancy, and for follow-up and research.}},
author = {{Bajc, Marika and Neilly, J and Miniati, M and Schuemichen, C and Meignan, M and Jonson, Björn}},
issn = {{1619-7070}},
language = {{eng}},
month = {{07}},
publisher = {{Springer}},
series = {{European Journal of Nuclear Medicine and Molecular Imaging}},
title = {{EANM guidelines for ventilation/perfusion scintigraphy : Part 2. Algorithms and clinical considerations for diagnosis of pulmonary emboli with V/P(SPECT) and MDCT.}},
url = {{http://dx.doi.org/10.1007/s00259-009-1169-y}},
doi = {{10.1007/s00259-009-1169-y}},
year = {{2009}},
}